|
ORC5L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.243300E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.378000E-02 |
| Normal-vs-Stage2 |
6.862000E-02 |
| Normal-vs-Stage3 |
5.605600E-01 |
| Normal-vs-Stage4 |
1.610120E-02 |
| Stage1-vs-Stage2 |
8.844200E-01 |
| Stage1-vs-Stage3 |
9.228200E-02 |
| Stage1-vs-Stage4 |
9.510600E-01 |
| Stage2-vs-Stage3 |
1.728800E-01 |
| Stage2-vs-Stage4 |
9.231400E-01 |
| Stage3-vs-Stage4 |
7.027800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.737700E-02 |
| Normal-vs-AfricanAmerican |
7.469600E-02 |
| Normal-vs-Asian |
6.872100E-02 |
| Caucasian-vs-AfricanAmerican |
1.142830E-01 |
| Caucasian-vs-Asian |
9.555600E-02 |
| AfricanAmerican-vs-Asian |
8.732200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.842700E-03 |
| Normal-vs-Female |
6.396000E-02 |
| Male-vs-Female |
4.092400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.522200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.390100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.866400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.582800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.372200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.298200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.381600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.707800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.503370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.987600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.355200E-01 |
| Normal-vs-Grade 2 |
2.946500E-02 |
| Normal-vs-Grade 3 |
1.021960E-01 |
| Normal-vs-Grade 4 |
1.166620E-01 |
| Grade 1-vs-Grade 2 |
4.442200E-01 |
| Grade 1-vs-Grade 3 |
4.384400E-01 |
| Grade 1-vs-Grade 4 |
4.877200E-01 |
| Grade 2-vs-Grade 3 |
3.055200E-01 |
| Grade 2-vs-Grade 4 |
5.819400E-01 |
| Grade 3-vs-Grade 4 |
6.943000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.425630E-01 |
| Normal-vs-ccB subtype |
3.393900E-02 |
| ccA subtype-vs-ccB subtype |
1.018980E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.420450E-02 |
| Normal-vs-N1 |
1.207990E-01 |
| N0-vs-N1 |
7.791200E-01 |
|
|
